Document is current
Any future updates will be listed below
-
Authors
Kimmel, Blaise R. https://orcid.org/0000-0002-9582-9887
Arora, Karan https://orcid.org/0000-0003-1472-1637
Chada, Neil C. https://orcid.org/0000-0003-4566-3564
Bharti, Vijaya
Kwiatkowski, Alexander J. https://orcid.org/0000-0001-5435-3555
Finkelstein, Jonah E.
Hanna, Ann
Arner, Emily N. https://orcid.org/0000-0003-3589-8829
Sheehy, Taylor L. https://orcid.org/0000-0002-3100-8115
Pastora, Lucinda E.
Yang, Jinming
Pagendarm, Hayden M. https://orcid.org/0000-0001-7611-6120
Stone, Payton T. https://orcid.org/0000-0002-8105-0610
Hargrove-Wiley, Ebony https://orcid.org/0000-0003-4452-4917
Taylor, Brandie C. https://orcid.org/0000-0002-4862-4678
Hubert, Lauren A.
Fingleton, Barbara M.
Gibson-Corley, Katherine N. https://orcid.org/0000-0002-1846-1580
May, Jody C. https://orcid.org/0000-0003-4871-5024
McLean, John A. https://orcid.org/0000-0001-8918-6419
Rathmell, Jeffrey C. https://orcid.org/0000-0002-4106-3396
Richmond, Ann https://orcid.org/0000-0002-9580-900X
Rathmell, W. Kimryn https://orcid.org/0000-0002-4984-0225
Balko, Justin M. https://orcid.org/0000-0002-4263-5974
Wilson, John T. https://orcid.org/0000-0002-9144-2634
-
Funding
Funding for this research was provided by:
Susan G. Komen (CCR19609205)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA245134)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA266767)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA274675)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA68485)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009592)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F32 CA288044)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K00 CA253718)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009592)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA217987)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA11601)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (SPORE 2P50CA098131–17)
National Science Foundation (CBET-1554623)
National Science Foundation (193793)
National Science Foundation (193793)
National Science Foundation (193793)
National Science Foundation (193793)
National Science Foundation (DMR 1852157)
Pharmaceutical Research and Manufacturers of America Foundation (Postdoctoral Fellowship in Drug Delivery)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007347)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM065086)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32DK101003)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32DK101003)
U.S. Department of Veterans Affairs (IK6B005225)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (BC170037)
- License Information
-
More Information
Article History
Received: 7 August 2023
Accepted: 7 March 2025
First Online: 11 June 2025
Competing interests
: J.T.W., K.A. and B.R.K. are inventors on United States Patent Application PCT/US2023/079884 ‘NANOBODY-DRUG CONJUGATES AND METHODS OF PREPARING THEREOF’ which describes nanobody conjugation and delivery technologies. J.T.W. has received research support from Incyte Corporation within the past 3 years. J.C.R. is an employee of Vanderbilt University Medical Center and appointed to the Vanderbilt University School of Medicine. He is a scientific advisory board member of Sitryx Therapeutics. J.C.M. and J.A.M. received support from Agilent Technologies in the form of a Thought Leader Award. Agilent is a commercial manufacturer of the MS instrumentation used in aspects of this work. J.A.M. is a member of the Scientific Advisory Board for MOBILion Systems, which is a manufacturer of high-resolution ion mobility–MS instrumentation. J.A.M. certifies that his contributions are scientifically objective and not influenced by his Scientific Advisory Board participation. J.M.B. receives research support from Genentech/Roche and Incyte Corporation, has received advisory board payments from AstraZeneca, Eli Lilly and Mallinckrodt and is an inventor on patents regarding immunotherapy targets and biomarkers in cancer.
